Biotest Aktiengesellschaft reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 516.1 million compared to EUR 515.6 million a year ago. Net loss was EUR 31.7 million compared to EUR 63.4 million a year ago.

Loss per share was EUR 0.81 compared to EUR 1.61 a year ago.